029HO13162 GERARD

Print/PDF
Registration Name SCHILLVIEW OMAN GERARD-ET
Registration Number HOUSA000052805723
Primary NAAB Code 029HO13162
Secondary Code(s) 529HO13162, 532HO13162, 530HO13162, 531HO13162, 533HO13162
Status Inactive
Controller Name ABS Global (29)
Date of Birth 2/27/2005
aAa 342
DMS 234,345
GFI 8.9%
Genetic Codes * TC TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire O-BEE MANFRED JUSTICE-ET
MGS MARA-THON BW MARSHALL-ET
Beta Casein A1A2
Kappa Casein -
Beta Lactoglobulin AB
INDEXES
NM$ -588, 95% R CM$ -597
NM Percentile 07% FM$ -574
GTPI 2111 GM$ -599
PRODUCTION TRAITS
41369 Dtrs 8793 herds 26 % US 99% R
Milk 262 Fat, % -43 , -0.20%
SCS 3.44, 99% R Protein, % 8 , 0.00%
Feed Saved -393 , 73% R Milking Speed 6.94 , 82% R
Health & Fertility
Productive Life -4.1      99% R Mastitis -4.7      98% R
Heifer Livability -0.2       93% R Metritis -1.6      95% R
Livability -4.0      98% R D. Abom -0.2      97% R
DPR -1.2      99% R Ketosis -1.3      95% R
HCR -0.9      98% R R. Placenta -0.9      96% R
CCR -2.1      99% R Milk Fever 0.2      89% R
SCR -        -
Calving Traits
Sire CE 1.1      99% R 46183 Obs
Daughter CE 2.0      99% R 15407 Obs, 23826 Dtrs
Sire SB 3.3      99% R 43199 Obs
Daughter SB 5.9      99% R 12835 Obs, Dtrs
Gestation Length -0.4      99% R 1175 Obs, 17531 Dtrs
Early First Calving 0.9      99% R 1507 Obs, 10274 Dtrs

CDCB April 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 04/2026
21374 Dtrs 5471 herds 99% R
PTA Type 0.12 UDC 0.16
FLC 0.15 BWC 2.00
Linear Traits
Stature 0.51
Tall
Strength 1.75
Strong
Body Depth 1.34
Deep
Dairy Form -0.34
Closed
Rump Angle -1.75
Flat
Thurl Width 2.11
Wide
Rear Legs-Side View -0.01
Straight
Rear Legs-Rear View 0.60
Straight
Foot Angle 0.84
Steep
Feet & Legs Score 0.10
High
F.U. Attachment 0.91
Strong
Rear Udder Height 0.24
High
Rear Udder Width 0.91
Wide
Udder Cleft -0.04
Weak
Udder Depth -0.46
Deep
Front Teat Placement -0.18
Wide
Rear Teat Placement -0.29
Wide
Teat Length 0.33
Long
-2
0
2

CDCB April 2026; Base of Evaluation: HO